PRTA FY 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$814,000-14.8% YoY

Gross Profit

-$50M-6145.2% margin

Operating Income

-$86M-10527.9% margin

Net Income

-$78M-9542.6% margin

EPS (Diluted)

$-1.95

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$54M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$419M

Total Liabilities

$146M

Stockholders' Equity

$273M

Cash & Equivalents

$376M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$814,000	$955,000	-14.8%
Gross Profit	-$50M	-$100M	+50.1%
Operating Income	-$86M	-$159M	+46.1%
Net Income	-$78M	-$156M	+50.1%